1.Sternocleidomastoid flaps for oral and maxillofacial reconstruction.
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1991;17(1):10-17
No abstract available.
4.Change of blood viscosity and deformability in oral squamous cell carcinoma patients.
Pil Young YUN ; Hoon MYOUNG ; Jong Ho LEE ; Pill Hoon CHOUNG ; Myung Jin KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2004;30(3):181-185
Malignant tumor have hypoxic cell fraction, which makes radio-resistant and hypoxia in tumor is a result from the blood flow decrease caused by increase in blood flow resistance. Blood viscosity increase is major factor of increased blood flow resistance and it could be attributed to the decrease in blood deformability index. For the evaluation of the change of blood viscosity and blood deformability in oral squamous cell carcinoma, we perform the test of the change of those factors between the normal control group and oral squamous cell carcinoma cell patient group. Relative viscosity measured against distilled water was 5.25+/-0.14 for normal control group, and 5.78+/-0.26 for the SCC patient group and there was statistical significance between the groups. However, there was no significant difference between the groups in blood viscosity between the groups by tumor size (T1+T2 vs T3+T4). Also, there was no significant difference between the normal control group and SCC patient group in blood deformability index and between the groups by tumor size (T1+T2 vs T3+T4). Increase in blood viscosity was confirmed with this study and it can be postulated that modification blood viscosity might contribute to decrease of hypoxia fraction in oral squamous cell carcinoma, thus improve the effect of radiotherapy and it can be assumed that the main factor of blood viscosity increase is not decrease of blood deformability in oral squamous cell carcinoma.
Anoxia
;
Blood Viscosity*
;
Carcinoma, Squamous Cell*
;
Humans
;
Radiotherapy
;
Viscosity
;
Water
5.Patients who leave the emergency department against medical advice.
Choung Ah LEE ; Joon Pil CHO ; Sang Cheon CHOI ; Hyuk Hoon KIM ; Ju Ok PARK
Clinical and Experimental Emergency Medicine 2016;3(2):88-94
OBJECTIVE: Discharge against medical advice (DAMA) from the emergency department (ED) accounts for 0.1% to 2.7% of all ED discharges. DAMA carries a risk of increased mortality and readmissions. Our aim was to investigate the general characteristics of DAMA patients and the differences between them and non-DAMA patients. METHODS: We reviewed data collected by the National Emergency Medical Center between 2010 and 2011. Subjects were categorized into 2 groups, namely, the DAMA group and the non-DAMA group. We compared these groups with respect to age, gender, trauma or non-trauma status, type of hospital, health insurance, level of consciousness on admission, and diagnosis. RESULTS: Of 8,000,529 patients, 222,389 (2.78%) left against medical advice. The risk factors for DAMA across all age groups were as follows: no medical insurance (odds ratio [OR], 1.993), initial response to voice (OR, 2.753) or pain (OR, 2.101), trauma admission (OR, 1.126), admission to a local emergency medical center (OR, 1.215), and increased age. A high risk of DAMA was observed among patients with immune, endocrine, psychiatric, neurological, circulatory diseases, and external causes of morbidity and mortality. CONCLUSION: Although DAMA cases account for only a small percentage of hospital discharges, they are important because DAMA patients have high readmission and mortality rates. It is therefore important to understand the general characteristics and predictors of DAMA in order to improve patient outcome and minimize the economic burden on the healthcare system.
Consciousness
;
Delivery of Health Care
;
Diagnosis
;
Emergencies*
;
Emergency Service, Hospital*
;
Humans
;
Insurance
;
Insurance, Health
;
Mortality
;
Organization and Administration
;
Patient Discharge
;
Risk Factors
;
Voice
6.Prognostic value of proliferation factors in oral squamous cell carcinoma.
Jun Young PAENG ; Yong Ju OK ; Pil Young YUN ; Hoon MYOUNG ; Soon Jung HWANG ; Byoung Moo SEO ; Jin Young CHOI ; Jong Ho LEE ; Pill Hoon CHOUNG ; Myung Jin KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2006;32(2):101-106
Purpose: The purpose of this study is to evaluate the value of proliferation factors, Ki67 and PCNA, as prognostic markers predicting the survival and neck metastasis in patients with oral cancer. Methods: 101 patients with HNSCCs, were followed retrospectively for a median period of 60 months(from 16 to 82 months). All tumors were resected surgically and examined by conventional light microscopy, immunohistochemistry. The age, sex, tumor location, clinical stage(size), metastasis, proliferative activity index(assessed by proliferating cell nuclear antigen(PCNA) and Ki67 immunoreactivity) were considered as potential prognostic factors and were correlated with patient survival. Results: Ki67 staining results ranged from 5% to 80% of tumor cell nuclei, with a median of 25%. PCNA staining results ranged from 1% to 90% with a median of 50%. With a cut-off point of 25%, patients with lower Ki67 scores showed survival advantages over those with higher Ki67 scores (p=0.0089). With cut-off point of 50%, patients with lower PCNA scores showed survival advantages over those with higher PCNA scores (p=0.0104). Pathologically neck node positive patients(n=27) showed higher PCNA expression(p=0.02) than pathologically negative neck node patients(n=39). Conclusions: The lower expressions of Ki67 and PCNA were associated with favorable prognosis such as higher survival rate and lower neck node metastasis.
Carcinoma, Squamous Cell*
;
Cell Nucleus
;
Humans
;
Immunohistochemistry
;
Microscopy
;
Mouth Neoplasms
;
Neck
;
Neoplasm Metastasis
;
Prognosis
;
Proliferating Cell Nuclear Antigen
;
Retrospective Studies
;
Survival Rate
7.Prognostic value of proliferation factors in oral squamous cell carcinoma.
Jun Young PAENG ; Yong Ju OK ; Pil Young YUN ; Hoon MYOUNG ; Soon Jung HWANG ; Byoung Moo SEO ; Jin Young CHOI ; Jong Ho LEE ; Pill Hoon CHOUNG ; Myung Jin KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2006;32(2):101-106
Purpose: The purpose of this study is to evaluate the value of proliferation factors, Ki67 and PCNA, as prognostic markers predicting the survival and neck metastasis in patients with oral cancer. Methods: 101 patients with HNSCCs, were followed retrospectively for a median period of 60 months(from 16 to 82 months). All tumors were resected surgically and examined by conventional light microscopy, immunohistochemistry. The age, sex, tumor location, clinical stage(size), metastasis, proliferative activity index(assessed by proliferating cell nuclear antigen(PCNA) and Ki67 immunoreactivity) were considered as potential prognostic factors and were correlated with patient survival. Results: Ki67 staining results ranged from 5% to 80% of tumor cell nuclei, with a median of 25%. PCNA staining results ranged from 1% to 90% with a median of 50%. With a cut-off point of 25%, patients with lower Ki67 scores showed survival advantages over those with higher Ki67 scores (p=0.0089). With cut-off point of 50%, patients with lower PCNA scores showed survival advantages over those with higher PCNA scores (p=0.0104). Pathologically neck node positive patients(n=27) showed higher PCNA expression(p=0.02) than pathologically negative neck node patients(n=39). Conclusions: The lower expressions of Ki67 and PCNA were associated with favorable prognosis such as higher survival rate and lower neck node metastasis.
Carcinoma, Squamous Cell*
;
Cell Nucleus
;
Humans
;
Immunohistochemistry
;
Microscopy
;
Mouth Neoplasms
;
Neck
;
Neoplasm Metastasis
;
Prognosis
;
Proliferating Cell Nuclear Antigen
;
Retrospective Studies
;
Survival Rate
8.Malignant ameloblastoma of mandible with lymph node metastasis.
Jee Hyun PARK ; Jae Hwa JEONG ; Pil Young YUN ; Jong Rak HONG ; Hoon MYOUNG ; Sun Jung HWANG ; Byoung Moo SEO ; Jin Young CHOI ; Jong Ho LEE ; Pill Hoon CHOUNG ; Myung Jin KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2003;29(5):298-300
Ameloblastomas are generally considered to be benign tumors of odontogenic epithelial origin with high local recurrence. Rarely ameloblastomas exhibit malignant behavior with development of metastases. In this report, we present a 19-year-old woman with ameloblastoma in the right ascending ramus and multiple recurrences. Eleven years after first therapy, ameloblastoma metastasized to ipsilateral submandibular lymph node. We also review literature about cause, treatment and work-up of malignant ameloblastoma.
Ameloblastoma*
;
Female
;
Humans
;
Lymph Nodes*
;
Mandible*
;
Neoplasm Metastasis*
;
Recurrence
;
Young Adult